|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | - | |
| Director/Board Member | 71 | 2019-06-30 | |
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| -0.55% | +2.85% | -17.02% | +2.47% | 190B | |
| -2.03% | +3.49% | -3.36% | +7.01% | 116B | |
| -3.95% | +1.58% | +11.45% | +71.74% | 63.71B | |
| -0.91% | +0.42% | +31.56% | +61.20% | 55.13B | |
| -1.11% | +4.62% | -8.42% | -36.83% | 49.41B | |
| -0.13% | +8.21% | +11.58% | -22.73% | 33.79B | |
| -0.63% | -4.75% | - | - | 30.74B | |
| -0.32% | +0.13% | +46.50% | -12.11% | 24.73B | |
| +0.89% | +13.57% | -4.69% | +22.43% | 23.85B | |
| Average | -0.87% | +2.73% | +8.45% | +11.65% | 58.76B | |
| Weighted average by Cap. | -1.14% | +4.03% | -0.25% | +12.35% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 77.32M 72.38M 66.05M 124M 8.51B 126M 849M 333M 4.26B 335M 328M 14.21B | 101M 87.35M 81.77M 74.61M 140M 9.61B 143M 959M 376M 4.81B 378M 370M 16.05B |
| Net income | -3.13M -2.71M -2.54M -2.32M -4.36M -299M -4.44M -29.79M -11.67M -149M -11.76M -11.5M -499M | 1.45M 1.26M 1.18M 1.07M 2.02M 138M 2.05M 13.78M 5.4M 69.16M 5.44M 5.32M 231M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
